Condition

Hematological Malignancies (4)

Cutaneous T Cell Lymphoma (1)

Hodgkin's Lymphoma (1)

Multiple Myeloma (1)

Overall Status

Recruiting (4)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Janssen Research & Development, LLC (3)

Mundipharma Research Limited (1)

Collaborator

Intervention

talquetamab (2)

teclistamab (1)

tinostamustine (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

Hematological Malignancies

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting

Hematological Malignancies

Teclistamab

Birmingham, Alabama
+80 more

Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting

Hematological Malignancies

Talquetamab

Birmingham, Alabama
+82 more

Aug 11, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting

Hematological Malignancies

Talquetamab

Birmingham, Alabama
+14 more

Jul 14, 2022

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting

Hematological Malignancies
+3 more

Tinostamustine

Phoenix, Arizona
+19 more

Apr 12, 2022